Royalty Pharma plc Class A (RPRX) Stock | Share Price | News

RPRX · Health Care · United States United States

Royalty Pharma plc Class A (RPRX) is a company in the Health Care sector, based in United States. The stock is held in 20 ETFs we track – with its largest weight of 0.40 % in XUHC (msci-usa-health-care). That means you can hold Royalty Pharma indirectly and diversified through an ETF savings plan.

Above-average ETF coverage: 20 of the 95 ETFs we cover hold Royalty Pharma, spread across 10 indices. That puts the stock in more ETFs than 84.5 % of the 4,362 stocks we cover.

Held in20 ETFs
Highest weight0.40 %
Indices10
SectorHealth Care
CountryUnited States
ISINGB00BMVP7Y09

Data note 1

Price chart

Data note 2

Performance

Performance
Year to date+59.0 %1 year+71.8 %
1 month+5.2 %3 months+14.5 %
Calendar year 2025+51.5 %
Calendar year 2026+59.9 %
52W

Data note 3

Risk metrics

Max drawdown-17.0 %
Volatility p.a.23.3 %
Best year2026: +59.9 %
Worst year2025: +51.5 %

Data note 4

Correlated with

The strongest co-movers on top, the most inverse below. Low or negative values improve portfolio diversification.

Data note 5

Key financials

Latest reported fiscal year (FY2025, period end 2025-12-31) as filed with the SEC.

Revenue2.4 bn $
Net income0.8 bn $
Diluted EPS1.78 $
Net margin32.4 %
Revenue growth+5.1 %
Revenue and profit by fiscal year
Fiscal yearRevenueNet incomeMargin
FY20232.41.148.2 %
FY20242.30.937.9 %
FY20252.40.832.4 %

Data note 6

Figures in USD bn. Source: SEC EDGAR (XBRL annual filings, public domain). US-listed SEC filers only.

Held in these ETFs

Data note 7

Want to know how much Royalty Pharma plc Class A overlaps with the rest of your portfolio? Use the Portfolio X-Ray or the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Royalty Pharma — the figure counts the ETFs holding both.

Data note 8

Latest Investment Intelligence News: Stocks